Schedule 13G ownership disclosure

Qualigen Therapeutics, Inc.

Security class unavailable · CUSIP: 74754R103

Event date: 2020-05-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-068446
Form type
SC 13G
Filer
AIxCrypto Holdings, Inc.
CIK
CIK 1460702
Filed
Jun 01, 2020
Reporting period
May 22, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub